← Leaderboards
Erik F. Young
Quicksilver Biosciences, Inc.
$632,568
Attributed
$1,265,136
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $817.3K · FY2021–22$1M$750K$500K$250K$0
'21
'22
Funding mix
By agency
NIH$1,265,136 · 1
By mechanism
R44$1,265,136 · 1
Top collaborators
- Kenneth L Shepard2 shared
Most similar at Quicksilver Biosciences, Inc.
Same institution · by research overlap
- Erik F Young$255,678
Others in their field
Other Emerging Leaders on “2019-Ncov”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$193,846,216
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,671,433
- Theresa Engel · Leidos Biomedical Research, Inc.$36,854,858
- Hanjoon Ryu$28,519,898
- Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn$23,410,676
- Yunda Huang · Fred Hutchinson Cancer Center$21,481,669
Research focus
2019-NcovAntigen DetectionAntibody DetectionBaseBinding ProteinsBiobankAntigen TestBiological SciencesCarbon NanotubesCommunicable DiseasesComplexCostCovid-19 DetectionCovid-19 DiagnosticCovid-19 PandemicCovid-19 TestingCovid TestDefectDesignDetectionDevicesDiagnosisDiagnostic AssayDiagnostic Tests